Clinical trial of medication to treat NF2 tumors starting soon
Tuesday, February 12, 2013 - 16:30
in Health & Medicine
Researchers are recruiting patients for a Phase II clinical trial to test a medication that may slow the progression of Neurofibromatosis Type-2, commonly referred to as NF2.